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We have recently demonstrated, by protein and cDNA sequence analyses, that prorenin converting enzyme (PRECE) in the ICR mouse subman- 
dibular gland is identical to the epidcnnal growth factor-binding protein (EGF-UP) type B. the mGK-13 gene product identified in Balb/c mouse. 
However, in the course of cDNA cloning, we noticed the presence of the other cDNA type highly homologous but not identical to the PRECE 
cDNA. The sequence of the newly identified cDNA was identical to that of the pSGP-2 cDNA cloned from NMRI mice, which also encodes 
EGF-BP type B different at 9 out of 261 amino acids from the mGK-I3 product. Although this difference has been explained by strain 
polymorphism, our results indicate that these two proteins are distinct gene products. The product of the newly identified cDNA also had a prorenin 
converting activity. Thus. the products of both cDNAs identified in previous and present studies arc involved in maturation of two bioactive 
polypcptides. renin and EGF. 
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1, INTRODUCTION 
Renin, an aspartyl protease. is the key enzyme of the 
renin-angiotensin system, and plays a pivotal role in the 
regulation of blood pressure [l]. It is produced from a 
larger, inactive precursor, prorenin. through endoprote- 
olysis at paired basic amino acids, Lys-Arg. during in- 
tracellular transport. Although the kidney is the major 
source of circulating renin. other tissues are also capa- 
ble of renin synthesis. For example, the submandibular 
gland (SMG) of male mice produces a large amount of 
renin. Renins in the kidney and the SMG are encoded 
by separate genes, Ren-I and Ren-2. respectively [2]. 
Recently, we have purified and characterized an en- 
doprotease involved in processing of Ren-2 prorenin. 
named prorenin converting enzyme (PRECE), from 
ICR mouse SMG [3-51. It consists of two polypeptide 
chains of 17 and 10 kDa linked by disulfide bonds [4]. 
Protein and cDNA sequence analyses [6] have revealed 
that PRECE is identical to the epidermal growth factor- 
binding protein (EGF-BP) type B, the product of the 
mGK-13 gene identified in Balb/c mouse [7]. EGF-BPS 
have been demonstrated to be members of the glandular 
kallikrcin family [8], and to be responsible for conver- 
sion of the 9.kDa EGF processing intcrmcdiate to ma- 
Ahhrtvirrriotts: SMG. submandibular gland: PRECE, prorcnin con- 
vcrting enzyme: EGF-BP. cpidcrmal growth fxtopbindinp protein: 
CHO. Chincsc hamster ovary. 
Cbrr(?Fponf/L~JJtc crddrcsa; K. Nakiiyam;l. lnstitutc of Biological SC&- 
CCS. University of Tsukuba. Tsukuba, Ibitraki 305, Japan. 
142 
ture EGF [9]. Thus, PRECE is involved in the matura- 
tion of two bioactive polypeptides produced in mouse 
SMG, Ren-2 renin and EGF. 
By the way. during the cloning process of the PRECE 
cDNA [6], we noticed the presence of the other popula- 
tion of cDNAs hybridizing with the PRECE probe but 
not identical to the PRECE cDNA. In this study, we 
sequenced the newly identified cDNA and examined the 
function of the encoded protein. 
2. MATERIALS AND METHODS 
cDNA cloning procedures wcrc described previously [G]. Both 
strands of the cloned cDNA (pPRECE-2) wcrc sequenced using the 
Sequcnase Version 2.0 kit (United States Biochemical Corp.). 
Prorenin converting activity of the protein encoded by the 
pPRECE-2cDNA was examined in a manner similar to that employed 
in the previous study (6J. Briefly. the cDNA insert was subcloned into 
the pSVD cxprcssion vecor [IO]. and transfccted into Chinese hamster 
ovary (CHO) cells. A cell line stably expressing the highest level of the 
protein (CHOIPR2) was then sclcctcd. The conditioned medium of 
CHO/PR?. cells cultured in a strum-free rncdium was trcatcd with 
trypsin. The [~‘Slmcthioninc-labclcd medium of CHO/MRB cells (a 
Rerr-2 prorcnin producing cell lint) [IO] wi\s then incubated with the 
trypsin-trcatcd or -untrcatcd conditioned medium of CHOlPRZ cells. 
and subjcctcd to immunoprscipitation with anti-Rr+? rcnin antisc- 
rum and SDS-PAGE analysis. 
3. RESULTS AND DISCUSSION 
In the previous study [6], WC scrcencd ~1 x 10” clones 
from the cDNA library of malt ICR mouse SMG by 
hybridization with the PRECE oligonucleotidc probe, 
and obtained ~100 pasitivc clones. Since the analyzed 
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Fig. I. Nucleotidc and deduced amino acid sequences of PRECE-2 along with those of PRECE-I. Residrtes of PRECE-I identical with those of 
PRECE-2 are indicated by hyphens. Proposed active site His. Asp and Ser residues are underlined. A consensus sequence for N-glycosylation is 
double underlined. 
twelve out of the positive clones appeared to share the 
same restriction patterns, we sequenced the longest 
clone (pPRECE-1) and demonstrated that the sequence 
is identical to the exon sequences of the mGK-13 gene 
encoding EGF-BP type B previously identified in Balbk 
mouse [7]. However. further analysis revealed that four 
out of the twelve clones showed restriction patterns 
somewhat different from those of the rest. i.e. the 
PRECE cDNA clones, when digested with some en- 
zymes, such as N.~p(7524)1 and RsaI (data not shown). 
Therefore, we sequenced a clone (pPRECE-2) longest 
among the four clones. Fig. I shows the nucleotide and 
deduced amino acid sequences of the pPRECE-2 along 
with those of the pPRECE-I. The pPRECE-2 cDNA 
sequence was identical to that of the pSGP-2 cDNA 
previously cloned from NMRI mouse, which is also 
proposed to code for EGF-BP type B [I I]. The protein 
encoded by the pSGP- 2 is different at only 9 out of 261 
amino acid residues from tllat encoded by the mGK-I 3 
[7.1!]. and this difference has been explained by strain 
polymorphism [7]. However, the fact that the pPRECE- 
1 and pPRECE-2 arc cloned from the same cDNA 
library of ICR mouse SMG indicate that these two 
proteins are the products of separate genes. Therefore, 
WC tentatively dcsignatcd the protein cncodcd by tire 
pPRECE-2 as PRECE-2, and redesignated that cn- 
coded by the pPRECE-I as PRECE.1. 
Since PRECE-I ;tnc! PRECE-2 share a high degree of 
amino acid sequcncc identity its dcscribcd above. it was 
reasonably speculated that PRECE-2 could also possess 
prorenin converting activity. To address this possibility, 
we initially transfected CHO cells with the PRECE-2 
expression plasmid, and then selected a cell line expres- 
Medium CHO/PR CHO/PR2 
Trypsin - + - + 
--c 
- -16 
-- NW 
# 
1 2 3 4 
Fig. 2. Trypsin trcarmcnt of the conditioned medium of CHOlPR2 
cclls.,Thc radiolabclcd conditioned medium of CHOIPR (lanes I and 
2) or CHO/PRZ (lanes 3 curd 4) cells was incubated with (lanes 2 and 
4) or without (lanes I ;md 3) trypsin (5 p@nl) at 4°C for 30 min. The 
rcactiott was stopped by the addition of soybean trypsin inhibitor (50 
&ml). The medium WIS then illlllrunoprccipitatcd with anti-PRECE- 
I antiserum [G]# and analyzed by SDS-PAGE under reducing condi- 
tions followed by fluoragntphy. 
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Fig. 3. Proxnin converting activity of PRECE-2. The radiolabeled 
conditioned medium of CHO/MRB cells (lOO& was incubated with 
the trypsin-treated (lanes 2 and 4) or -untreated (lanes I and 3) condi- 
tioncd medium of CHO/PR (lanes I and 2) or CHO/PRZ (lanes 3 and 
4) cells (100~1) in a final volume of 500)!1 of 0.1 M TrisIHCI (pH 8.0) 
at 37°C for 4 h. immunoprecipitarcd with anti-Rerl-2 rcnin antiserum, 
and analyzed by SDS-PAGE under reducing conditions followed by 
Auorography. The CHOIMRB medium was also incubated with (Ixne 
6) or without (lane 5) 100 ng of PRECE-I purirled from ICR n?~::se 
SMG [4] as a positive or negative control. respectively. The arrowhead 
and arrow indicate positions of prorcnin and renin. respectively. 
sing the highest level of the protein (CHOiPR2). As 
shown in Fig. 2, CHO/PRZ cells secreted a single chain 
form of PRECE-2 (lane 3) like CHO/PR cells expressing 
PRECE-I (lane 1) [6]; the doublet SDS-PAGE bands of 
the PRECE-I and PRECE-2 molecules in lanes 1 and 
3. respectively. could be derived from heterogeneity in 
glycosylation. since both of them have a potential N- 
glycosylation site in the I7-kDa chain (Fig. 1) and the 
molecules treated with endoglycosidase F migrated as 
singlets on SDS-PAGE (data not shown). Therefore. we 
treated the conditioned medium of CHO/PR2 cells with 
trypsin. which has been demonstrated to effectively con- 
vert the PRECE-I precursor to a two-chain. enzymati- 
tally active form (lane 2) [6]. The single chain PRECE-2 
was converted to a two-chain form by the trypsin treat- 
ment (lane 4): the doublet bands at 20 and 17 kDa in 
lanes 2 and 4 are derived from gIycosyIation heterogene- 
ity of the 17-kDa chain (data not shown). Then, the 
radiolabeled conditioned medium of CHOiMRB cells. 
which stably express Re+2 prorenin [ 101, was incubated 
with the trypsin-treated or -untreated CHO/PR2 mc- 
dium. As shown in Fig. 3. like CH )/PR medium (lanes 
1 and 2). the trypsin-treated (lane 4) but not -untreated 
(lane 3) medium of CHO/PRZ cell; gave rise to convcr- 
sion of Rcrt-2 prorenin to renin. These observations 
indicate that the two-chain form of PRECE-2 also pos- 
sesscs prorcnin converting activity. 
Data prcscntcd hcrc dcmonstratc that two isoforms 
of PRECE, clesignatcd PRECE-I and PRECE-2, struc- 
turally related to each other arc prcscnt in ICI< mouse 
SMG. PRECE-1 and PRECE-2 arc idcnticcd to the 
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product of the mGK-13 gene previously cloned from 
Balb/c mouse [7] and that of pSGP-2 cDNA from 
NMRI mouse [11]. respectively. Both the mGK-I 3 and 
the pSGP-2 encode EGF-BP type B. Thus. both en- 
zymes we identified are involved in maturation of two 
bioactive polypeptides produced in mouse SMG. Ret1-2 
renin and EGF. 
Richards and his colleagues [S] have reported that the 
mouse glandular kallikrein gene family consists of at 
least 25 members, designated mGK-I to mGK-25, in- 
cluding some pseudogenes. and ten of them are ex- 
pressed in the SMG. Since the gene corresponding to 
the pSGP-2 cDNA was not isolated from the Ralb/c 
mouse genomic library. they explained that the se- 
quence heterogeneity between the mGK-13 and the 
pSGP-2 could be due to strain polymorphism [7]. How- 
ever. our data unequivocally exclude this possibility. 
PRECE-I and PRECE-2 are distinct gene products. 
The increasing list of glandular kallikrein family 
members and their substrates highlights the diverse sub- 
strate specificity of this structurally related family [ 121. 
In this context. it is very interesting whether other kal- 
likreins. especially EGF-BP type A and type C which 
both are also involved in maturation of EGF. possess 
prorenin converting activity. To address this problem. 
experiments are under way in our laboratory. 
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